Synergistic Effects of LYTONIC™ Capsules and Gel

Published on
Embed video
Share video
Ask about this video

Scene 1 (0s)

[Audio] The synergistic effects of LYTONIC capsules and gel in treating diabetic foot ulcers are the subject of our presentation today. Conducted by Professor Dr. S. Papageorgiou, a leading researcher in the field, this randomized clinical trial sought to determine the effectiveness of LYTONIC capsules and gel in reducing wound size and promoting healing in patients with diabetic foot ulcers. We will now delve into the findings of this pioneering research..

Scene 2 (28s)

[Audio] As a renowned Research and Development Director, Dr. Papageorgiou has led this groundbreaking study, leveraging his extensive experience in advanced medical research and clinical application. With a strong track record of developing innovative therapeutic solutions, he has consistently pushed the boundaries of scientific inquiry. His leadership in combining systemic and topical approaches has underscored his commitment to enhancing patient outcomes and addressing critical healthcare challenges..

Scene 3 (58s)

[Audio] The Attikon General University Hospital of Athens is a hub of excellence in research and healthcare, located in Athens, Greece. As a critical pillar of the Stavros Niarchos Foundation Health Initiative, it is dedicated to improving public health infrastructure and advancing medical research. With state-of-the-art facilities, the hospital plays a dual role as a leading clinical center and a pioneering research institution, focusing on cutting-edge medical treatments, patient-centered care, and groundbreaking clinical trials that contribute to global advancements in healthcare. Its collaboration with esteemed researchers and professionals fosters an environment that bridges science and practice, making it a preferred site for high-impact studies, including those in diabetic care, wound healing, and chronic disease management..

Scene 4 (1m 46s)

[Audio] . Table 1: Patient Demographics and Target Ulcer Characteristics.

Scene 5 (1m 51s)

[Audio] The results demonstrate that the average ulcer area diminished substantially across all treatment groups. The control group witnessed a minor decrease of 4% in ulcer surface area, whereas the capsules-only group experienced a notable reduction of 31%, the gel-only group observed a reduction of 26%, and the combination therapy group achieved a remarkable reduction of 59%. These findings suggest that LYTONIC capsules and gel exhibit a synergistic effect when employed jointly, leading to enhanced wound healing outcomes..

Scene 6 (2m 26s)

[Audio] The clinical improvement outcomes reveal that the control group experienced a mere 4.0% wound reduction. In stark contrast, the groups receiving LYTONIC Capsules Only and LYTONIC Gel Only achieved notable improvements, boasting wound reductions of 30.9% and 27.4%, respectively. However, it was the combination of LYTONIC Capsules and LYTONIC Gel that yielded the most striking outcome, with a remarkable 59.0% wound reduction. This implies that the synergistic effects of the two treatments likely played a crucial role in amplifying the therapeutic response..

Scene 7 (3m 3s)

[Audio] Please let me know if this is what you were looking for. I'll be happy to help with any further requests..

Scene 8 (3m 9s)

[Audio] The results demonstrate a significant decrease in wound size across all groups. The control group exhibited the smallest reduction, with only 4% of wounds showing improvement. In contrast, the LYTONIC capsules-only group witnessed a notable 30.9% reduction in wound size, whereas the gel-only group experienced a 27.4% reduction. The combination therapy group, however, achieved the most impressive outcome, with a remarkable 59% reduction in wound size. This synergy between the capsules and gel illustrates the potential advantages of employing both treatments jointly to foster optimal healing..

Scene 9 (3m 46s)

[Audio] The data presented here shows that there was a significant reduction in inflammatory markers across all groups, indicating a positive impact on the body's response to injury. The control group showed minimal change, while the LYTONIC capsule-only and gel-only groups exhibited moderate reductions. However, it was the combination therapy of LYTONIC capsules and gel that demonstrated the most pronounced decrease in inflammatory markers, suggesting a synergistic effect between the two treatments. This finding supports the idea that the combined use of LYTONIC capsules and gel may be more effective in promoting wound healing and reducing inflammation than using either treatment alone..

Scene 10 (4m 26s)

[Audio] The data presented here shows that before treatment, all groups had elevated levels of oxidative stress markers, indicating high levels of oxidative stress in these patients. After treatment, a significant reduction in oxidative stress marker levels was observed across all groups, with the greatest reduction seen in the group receiving both capsules and gel, suggesting a synergistic effect in reducing oxidative stress in diabetic foot ulcer patients..

Scene 11 (4m 54s)

[Audio] The results of this study demonstrate the synergy between LYTONIC 500mg Capsules and LYTONIC Gel in treating diabetic foot ulcers. In comparison to other treatments, the combined therapy showed the highest rate of wound reduction, indicating faster healing. Additionally, it led to substantial improvements in inflammatory markers and oxidative stress markers, highlighting its anti-inflammatory and antioxidant properties. Furthermore, the combined treatment resulted in faster and more effective reduction of ulcer surface area, illustrating the complementary benefits of systemic and topical therapies. Overall, this study shows that the combined use of LYTONIC 500mg Capsules and LYTONIC Gel offers a new and highly effective approach to managing diabetic foot ulcers, with potential benefits including reduced complications, improved patient outcomes, and enhanced quality of life..

Scene 12 (5m 51s)

[Audio] The revolutionary nano complex developed by Bochery has shown remarkable results in advancing the recovery of diabetic foot ulcers. We believe that this innovative solution will make a significant difference in the lives of those affected by DFUs..